Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes

被引：52
|
作者：
Hedman, CA
Lindstrom, T
Arnqvist, HJ
机构：
[1] Linkoping Univ, Dept Med & Care, Div Internal Med, Linkoping, Sweden
[2] Linkoping Univ, Fac Hlth Sci, Dept Biomed & Surg, Div Cellbiol, Linkoping, Sweden
来源：
DIABETES CARE | 2001年 / 24卷 / 06期
关键词：
D O I：
10.2337/diacare.24.6.1120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1120 / 1121
页数：2
相关论文
共 50 条
  • [21] A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro insulin in patients with type 1 diabetes
    Korsatko, S.
    Glettler, K.
    Olsen, K. J.
    Wutte, A.
    Bock, G.
    Koehler, G.
    Mader, J. K.
    Semlitsch, B.
    Pieber, T. R.
    DIABETES OBESITY & METABOLISM, 2013, 15 (03): : 241 - 245
  • [22] Comparison of small preprandial doses of insulin lispro to human regular insulin in type 2 diabetes
    Bruns, W
    Fischer, S
    Kohler, C
    Melchert, J
    Fuhrmann, G
    Gudat, U
    Frank, M
    Hanefeld, M
    DIABETES, 1999, 48 : A352 - A353
  • [23] Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents
    Holcombe, JH
    Zalani, S
    Arora, VK
    Mast, CJ
    CLINICAL THERAPEUTICS, 2002, 24 (04) : 629 - 638
  • [24] Comparison of a twice daily injection of insulin aspart 50 with insulin aspart 30 in patients with poorly controlled type 2 diabetes
    Shi, Chunhong
    Sun, Luyan
    Bai, Ran
    Wang, Hao
    Liu, Dan
    Du, Jianling
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (06) : 1091 - 1096
  • [25] Response to Jovanovic for the Comments on Our Study "Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial"
    van Bon, Arianne C.
    DeVries, J. Hans
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (08) : 871 - 871
  • [26] Comparison of the pharmacodynamics and pharmacokinetics of bolus subcutaneous insulin glulisine and insulin lispro in obese patients with type 2 diabetes
    Luzio, SD
    Peter, R
    Dunseath, GJ
    Mustafa, N
    Owens, DR
    DIABETOLOGIA, 2005, 48 : A307 - A307
  • [27] A direct comparison of pharmacodynamics and pharmacokinetics of insulin detemir and neutral protamine lispro (NPL) insulin in subjects with type 1 diabetes
    Korsatko, S.
    Glettler, K.
    Olsen, K. J.
    Wutte, A.
    Bock, G.
    Koehler, G.
    Mader, J. K.
    Semlitsch, B.
    Pieber, T. R.
    DIABETOLOGIA, 2009, 52 : S200 - S200
  • [28] A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes
    Bramlage, Peter
    Tittel, Sascha R.
    Muether, Silvia
    Reinhart-Steininger, Birgit
    Haberland, Holger
    Khodaverdi, Semik
    Zimny, Stefan
    Ohlenschlaeger, Ute
    Lanzinger, Stefanie
    Haak, Thomas
    ACTA DIABETOLOGICA, 2022, 59 (11) : 1453 - 1460
  • [29] CONTINUOUS SUBCUTANEOUS INSULIN INFUSION - COMPARISON OF PLASMA-INSULIN PROFILES AFTER INFUSION OR BOLUS INJECTION OF THE MEALTIME DOSE
    HOME, PD
    PICKUP, JC
    KEEN, H
    ALBERTI, KGMM
    PARSONS, JA
    BINDER, C
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (05): : 439 - 442
  • [30] Continuous subcutaneous insulin infusion (CSII) of insulin aspart vs. insulin lispro in paediatric subjects (ages 4 to 18 years) with type 1 diabetes (T1D)
    Ternand, C.
    Weinzimer, S. A.
    Laffel, L. M. B.
    Howard, C.
    Chang, C.-T.
    Becker, D. J.
    DIABETOLOGIA, 2007, 50 : S83 - S84
12345